Study Investigating PK, PD, Efficacy, Safety, and Immunogenicity of Biosimilar Denosumab (GP2411) in Patients With Postmenopausal Osteoporosis

Clinical trial NCT03974100 · COMPLETED

Trial details

NCT number: NCT03974100
Sponsor: Sandoz
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Postmenopausal Women With Osteoporosis

Start date: 2019-07-02
Primary completion: 2022-04-22
Enrollment: 527

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.